BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21964465)

  • 1. Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.
    Fogarty EA; Matulis CK; Kraus WL
    Mol Cell Endocrinol; 2012 Jan; 348(1):331-8. PubMed ID: 21964465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
    Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
    Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.
    Qiu C; Liu X; Wang J; Zhao Y; Fu Q
    Osteoporos Int; 2014 Apr; 25(4):1357-67. PubMed ID: 24504099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts.
    Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R
    J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
    Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
    Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.
    Lupien M; Jeyakumar M; Hébert E; Hilmi K; Cotnoir-White D; Loch C; Auger A; Dayan G; Pinard GA; Wurtz JM; Moras D; Katzenellenbogen J; Mader S
    Mol Endocrinol; 2007 Apr; 21(4):797-816. PubMed ID: 17299137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.
    Levy N; Tatomer D; Herber CB; Zhao X; Tang H; Sargeant T; Ball LJ; Summers J; Speed TP; Leitman DC
    Mol Endocrinol; 2008 Feb; 22(2):287-303. PubMed ID: 17962382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Synonymous Ala87 Mutation of Estrogen Receptor Alpha Modifies Transcriptional Activation Through Both ERE and AP1 Sites.
    Fernández-Calero T; Flouriot G; Marín M
    Methods Mol Biol; 2016; 1366():287-296. PubMed ID: 26585143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
    Zhang Q; Kleeberger SR; Reddy SP
    Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.
    Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H
    J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
    Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
    Weatherman RV; Clegg NJ; Scanlan TS
    Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway.
    Heldring N; Isaacs GD; Diehl AG; Sun M; Cheung E; Ranish JA; Kraus WL
    Mol Endocrinol; 2011 Apr; 25(4):564-74. PubMed ID: 21330404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
    Singleton DW; Feng Y; Burd CJ; Khan SA
    Endocrinology; 2003 Jan; 144(1):121-8. PubMed ID: 12488337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.